Search Tag: abionic
2024 22 Feb
Abionic SA, a Swiss leader in nanofluidic point-of-care diagnostic solutions, is thrilled to announce the appointment of Patrick Pestalozzi as its new Chief Executive Officer, effective April 1st, 2024. A former Management Consultant, Silicon Valley executive, and Entrepreneur, Patrick brings to Abionic 3 decades of global experience, more...Read more
2023 26 Oct
Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partnership will enable Fapon to engage in the research, development,...Read more
2022 14 Oct
The problem of antimicrobial resistance and the use of a clinical decision score and point-of-care testing biomarkers, such as CRP and PSP, to help solve this problem. Introduction Infectious diseases are a public health issue around the world, with bacterial, viral, parasitic, or fungal-related diseases responsible for 26% of mortality...Read more
2022 16 Sep
Hybrid Event On September 16, 2022, the Global Sepsis Alliance and the Sepsis Stiftung will join forces to host a unique event celebrating a decade of World Sepsis Day – both in person in Berlin, as well as live streamed on this website. The event is split up into 3 parts – a scientific symposium with renowned speakers from all over the...Read more
2022 09 Aug
BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transitional regulation allows established, non-IVDR-certified...Read more
2021 08 Apr
On April 6th, Abionic and Palex joined forces to participate in the first day of GaliSepsis, the National Sepsis Course hosted and organized virtually by the Ourense University Hospital Complex (CHUO) in Spain. With the aim of updating the most important concepts and reviewing the latest developments in the management of patients with sepsis, three...Read more
2021 08 Apr
On April 6th, Abionic and Palex joined forces to participate in the first day of GaliSepsis, the National Sepsis Course hosted and organized virtually by the Ourense University Hospital Complex (CHUO) in Spain. With the aim of updating the most important concepts and reviewing the latest developments in the management of patients with sepsis, three...Read more
2020 17 Nov
Speakers Prof. Dr Steven Opal Alpert Medical School of Brown University, USA Dr Bruno Francois Centre Hospitalier Universitaire de Limoges, France Dr Angelo Giacomucci Unita di Terapia Intensiva, Azienda Ospedaliera di Perugia, Italy Dr Phillipe Eggimann Centre Hopsitalier Universitaire Vaudois, Switzerland Find Abionic on Social...Read more